about
Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats.Increased strength of erythrocyte aggregates in blood of patients with inflammatory bowel disease.The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Infliximab treatment for Crohn's disease
@ast
Infliximab treatment for Crohn's disease
@en
Infliximab treatment for Crohn's disease
@nl
type
label
Infliximab treatment for Crohn's disease
@ast
Infliximab treatment for Crohn's disease
@en
Infliximab treatment for Crohn's disease
@nl
prefLabel
Infliximab treatment for Crohn's disease
@ast
Infliximab treatment for Crohn's disease
@en
Infliximab treatment for Crohn's disease
@nl
P2860
P356
P1476
Infliximab treatment for Crohn's disease
@en
P2093
P2860
P304
P356
10.1136/PMJ.77.909.436
P407
P577
2001-07-01T00:00:00Z